Publisher
JSC National Scientific Medical Research Center
Reference28 articles.
1. Anwar, N., Badar, F., Yusuf, M.A., 2008. Profile of patients with colorectal cancer at a tertiary care cancer hospital in Pakistan. Ann. N. Y. Acad. Sci. 1138, 199-203. https://doi.org/10.1196/annals.1414.026
2. Bhurgri, Y., Khan, T., Kayani, N., Ahmad, R., Usman, A., Bhurgri, A., Bashir, I., Hasan, S., Zaidi, S.M.H., 2011. Incidence and current trends of colorectal malignancies in an unscreened, low risk population. Asian Pacific J. Cancer Prev. 12, 703-708.
3. Brigger, I., Dubernet, C., Couvreur, P., 2012. Nanoparticles in cancer therapy and diagnosis. Adv. Drug Deliv. Rev. 64, 24-36. https://doi.org/10.1016/j.addr.2012.09.006
4. Duffy, M.J., Synnott, N.C., Crown, J., 2017. Mutant p53 as a target for cancer treatment. Eur. J. Cancer 83, 258-265. https://doi.org/10.1016/j.ejca.2017.06.023
5. Frebourg, T., Friend, S.H., 1992. Cancer risks from germline p53 mutations. J. Clin. Invest. 90, 1637-1641. https://doi.org/10.1172/JCI116034